Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,847 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,849 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00423293 | Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | completed | Phase 2 | 63 | Radiation Therapy Oncology GroupNETWORK | 2 | Feb 27, 2019 | clinicaltrials |
| NCT00483834 | A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Feb 15, 2019 |
| clinicaltrials |
| NCT00806663 | FOLFIRI and Sunitinib in Metastatic Colorectal Cancer | completed | Phase 2 | 22 | Central European Society for Anticancer Drug ResearchOTHER | 1 | Feb 6, 2019 | clinicaltrials |
| NCT00483080 | Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC) | completed | Phase 2 | 46 | AGC Biologics S.p.A.INDUSTRY | 1 | Jan 16, 2019 | clinicaltrials |
| NCT00773097 | Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma | completed | Phase 2 | 46 | Robert SchoenOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT01220063 | RSHF in Colorectal Cancer(RS CAMPTO) | completed | Phase 2 | 48 | Institut Cancerologie de l'OuestOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT02305758 | Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 130 | AbbVieINDUSTRY | 0 | Nov 20, 2018 | clinicaltrials |
| NCT02465502 | Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer | completed | Phase 2 | 59 | BayerINDUSTRY | 1 | Nov 7, 2018 | clinicaltrials |
| NCT02295774 | Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA | completed | Phase 2 | 10 | Cosmo Technologies LtdINDUSTRY | 1 | Nov 5, 2018 | clinicaltrials |
| NCT00257322 | Cellular Immune Augmentation in Colon and Rectal Cancer | completed | Phase 2 | 20 | University of California, IrvineOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT01661972 | Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer(X-TRAP) | completed | Phase 1 / Phase 2 | 63 | John Strickler, M.D.OTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT01972451 | Feasibility of Reduction in Right Sided Bowel Cancer Through Contrast Enhanced Colonoscopy(CONSCOP) | completed | Phase 2 | 1,320 | Lisette NixonOTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT00004142 | Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver | completed | Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 26, 2018 | clinicaltrials |
| NCT00003441 | Irofulven in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 26 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 25, 2018 | clinicaltrials |
| NCT01321957 | Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer(CHARTA) | completed | Phase 2 | 250 | Martin-Luther-Universität Halle-WittenbergOTHER | 1 | Oct 25, 2018 | clinicaltrials |
| NCT00094809 | Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer | completed | Phase 2 | 252 | AmgenINDUSTRY | 0 | Oct 17, 2018 | clinicaltrials |
| NCT00418938 | SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial | completed | Phase 2 | 266 | AmgenINDUSTRY | 0 | Oct 17, 2018 | clinicaltrials |
| NCT00896454 | Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium | completed | Phase 2 | 33 | AmgenINDUSTRY | 5 | Oct 17, 2018 | clinicaltrials |
| NCT01117428 | Sym004 in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 111 | Symphogen A/SINDUSTRY | 3 | Oct 15, 2018 | clinicaltrials |
| NCT00613080 | Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | completed | Phase 2 | 79 | Radiation Therapy Oncology GroupNETWORK | 2 | Sep 25, 2018 | clinicaltrials |
| NCT00551213 | A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) | completed | Phase 2 | 67 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 24, 2018 | clinicaltrials |
| NCT00310076 | Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer | completed | Phase 2 | 29 | Wake Forest University Health SciencesOTHER | 1 | Aug 23, 2018 | clinicaltrials |
| NCT00614393 | Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004) | completed | Phase 2 | 558 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 8, 2018 | clinicaltrials |
| NCT01348412 | Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure(HEARTO) | completed | Phase 2 | 31 | Centre Georges Francois LeclercOTHER | 1 | Jul 16, 2018 | clinicaltrials |
| NCT01632722 | Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets | completed | Phase 2 | 79 | Yonsei UniversityOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT01661764 | Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention | completed | Phase 2 | 141 | Vanderbilt UniversityOTHER | 1 | Jun 8, 2018 | clinicaltrials |
| NCT00503685 | Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy | completed | Phase 2 | 65 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01340300 | Exercise and Metformin in Colorectal and Breast Cancer Survivors | completed | Phase 2 | 139 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT00686166 | S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer | completed | Phase 2 | 83 | SWOG Cancer Research NetworkNETWORK | 1 | May 18, 2018 | clinicaltrials |
| NCT00003344 | Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer | completed | Phase 1 / Phase 2 | 49 | Medical University of South CarolinaOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT01285778 | Vectibix for the Treatment of Anal Cancer(VITAL) | completed | Phase 2 | 58 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT01288339 | Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer(PULSE) | completed | Phase 2 | 78 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT01929421 | A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer. | completed | Phase 2 | 36 | Gachon University Gil Medical CenterOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT01919879 | Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal Cancer | completed | Phase 2 | 75 | UNICANCEROTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03517618 | TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC | completed | Phase 2 | 41 | TTY BiopharmINDUSTRY | 1 | May 7, 2018 | clinicaltrials |
| NCT00149396 | Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 32 | MediGeneINDUSTRY | 1 | Apr 24, 2018 | clinicaltrials |
| NCT02284139 | Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects | completed | Phase 2 / Phase 3 | 90 | Dong-A University HospitalOTHER | 1 | Apr 23, 2018 | clinicaltrials |
| NCT01975454 | Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 62 | Shanghai University of Traditional Chinese MedicineOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT01762293 | A Study of Famitinib in Patients With Advanced Colorectal Cancer | completed | Phase 2 | 154 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT00114231 | Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer | completed | Phase 2 | 90 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT02015754 | Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer | completed | Phase 2 | 14 | Yale UniversityOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT00831181 | Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer | completed | Phase 2 | 27 | Beth Israel Medical CenterOTHER | 1 | Mar 20, 2018 | clinicaltrials |
| NCT01923116 | Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia(VACCAIN-T) | completed | Phase 1 / Phase 2 | 40 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Mar 15, 2018 | clinicaltrials |
| NCT00398879 | Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients | completed | Phase 2 | 381 | AEterna ZentarisINDUSTRY | 1 | Mar 14, 2018 | clinicaltrials |
| NCT03085992 | Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer(TRUST) | completed | Phase 2 | 49 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Mar 14, 2018 | clinicaltrials |
| NCT01585428 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers | completed | Phase 2 | 29 | National Cancer Institute (NCI)NIH | 1 | Mar 7, 2018 | clinicaltrials |
| NCT02949791 | HIPEC Using High Intra-abdominal Pressure(HIPEC-IAP) | completed | Phase 2 | 38 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT01462513 | L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases(LICC) | completed | Phase 2 | 122 | Prof. Dr. Carl SchimanskiOTHER | 2 | Feb 13, 2018 | clinicaltrials |
| NCT02353858 | Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer(HT01) | completed | Phase 2 | 78 | University Hospital TuebingenOTHER | 1 | Feb 13, 2018 | clinicaltrials |
| NCT01589471 | The Value of Botox-A for Management of Low Anterior Resection Syndrome | completed | Phase 2 | 23 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Feb 12, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Feb 27, 2019source: clinicaltrials